Wednesday, February 1, 2017
Japans Takeda committed to single-digit U.S. drug price rises
😊 67.3 😒 18.5 😐 7.8 TOKYO (Reuters) - Japans largest drugmaker, Takeda Pharmaceuticals Co, on Wednesday said it would maintain its pricing model in the U.S. market, brushing off demands by U.S. President Donald Trump for drugmakers to offer cheaper drugs.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment